Table of Contents

Scalp Hair

Scalp hair samples were collected from ~59,000 adult Lifelines participants during 2A Visit 2. The main aim of hair collection was to use the samples for the assessment of hormone levels, e.g. cortisol (section: physical state).
The hair collection protocol was piloted in a subcohort of 300 participants in september 2013 (during 1A Visit 2) as an additional assessment initiated by researchers at the Department of Internal Medicine of Erasmus University, the Netherlands. During 2A visit 2 it was extended to ~59.000 participants. ~6000 samples have been analyzed for cortisol and cortisone and this data can be requested by sending an e-mail to data@lifelines.nl.

Background

Cortisol levels are typically assessed in serum, saliva, or urine samples. However, due to the circadian rhythm of cortisol, its pulsatile secretion, and the daily variation due to changing circumstances like acute stress, these samples provide non-representative snapshots of chronic cortisol levels in the human body. For that reason, a novel non-invasive parameter to measure cortisol using scalp hair was developed1), providing the unique opportunity to measure long-term cortisol levels that reflect the mean levels of several months (since hair grows with an average of 1 cm per month). Using this technique, it is now possible to study chronic cortisol levels over time in very large cohorts2).

Protocol

During 2A visit 2, participants were asked to provide a lock of hair. Nurse practitioners that assisted in the visit cut off a lock of hair close to the scalp using clean scissors. The lock of hair was placed in an envelope, clearly marked and registered, and stored at room temperature.
Participants also filled in a questionnaire about their hair, see the list of questions below.

Publications using Lifelines hair samples

1)
Manenschijn L et al. (2011). Evaluation of a method to measure long term cortisol levels. Steroids 76(10-11):1032-1036
2)
Russell E. et al (2015). Toward standardization of hair cortisol measurement: results of the first international interlaboratory round robin. Therapeutic Drug Monitoring 37(1):71-75